Carregant...

mTOR signaling: new networks for ALL

Compared with rapamycin, mammalian target of rapamycin (mTOR) dual inhibitors have shown improved ability to kill acute lymphocytic leukemia (ALL) cells in preclinical models. In this issue of Blood, Yun et al have identified novel signaling pathways downstream of mTOR that are disrupted by dual inh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autor principal: Fruman, David A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891950/
https://ncbi.nlm.nih.gov/pubmed/27257176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-03-703199
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!